1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Genital Herpes Treatment Drugs Market
2.3. Global Genital Herpes Treatment Drugs Market, By Drug Class, 2025 (US$ Million)
2.4. Global Genital Herpes Treatment Drugs Market, By Geography, 2025 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2025

3. Genital Herpes Treatment Drugs Market: Competitive Analysis
3.1. Market Positioning of Key Genital Herpes Treatment Drugs Market Vendors
3.2. Strategies Adopted by Genital Herpes Treatment Drugs Market Vendors

4. Genital Herpes Treatment Drugs Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Genital Herpes Treatment Drugs Market Value, 2024 - 2034, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. Porter's Five Force Model
4.5.1. Supplier Power
4.5.2. Buyer Power
4.5.3. Threat Of Substitutes
4.5.4. Threat Of New Entrants
4.5.5. Competitive Rivalry
4.6. PESTEL Analysis
4.6.1. Political Landscape
4.6.2. Economic Landscape
4.6.3. Social Landscape
4.6.4. Technology Landscape
4.6.5. Environmental Landscape
4.6.6. Legal Landscape

5. Genital Herpes Treatment Drugs Market: By Drug Class, 2024-2034, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2025 Versus 2034
5.3. Market Segmentation
5.3.1. Acyclovir
5.3.2. Famciclovir
5.3.3. Valacyclovir
5.3.4. Pipeline Analysis
5.3.4.1. Phase III Drugs
5.3.4.1.1. GEN-003
5.3.4.1.2. VCL-HB01
5.3.4.2. Tabular Representation of Drug Pipeline in Phase II and I

6. North America Genital Herpes Treatment Drugs Market, 2024-2034, USD (Million)
6.1. Market Overview
6.2. Genital Herpes Treatment Drugs Market: By Drug Class, 2024-2034, USD (Million)
6.3. Genital Herpes Treatment Drugs Market: By Region, 2024-2034, USD (Million)
6.3.1.North America
6.3.1.1. U.S.
6.3.1.1.1. Genital Herpes Treatment Drugs Market: By Drug Class, 2024-2034, USD (Million)
6.3.1.2. Canada
6.3.1.2.1. Genital Herpes Treatment Drugs Market: By Drug Class, 2024-2034, USD (Million)
6.3.1.3. Rest of North America
6.3.1.3.1. Genital Herpes Treatment Drugs Market: By Drug Class, 2024-2034, USD (Million)

7. UK and European Union Genital Herpes Treatment Drugs Market, 2024-2034, USD (Million)
7.1. Market Overview
7.2. Genital Herpes Treatment Drugs Market: By Drug Class, 2024-2034, USD (Million)
7.3. Genital Herpes Treatment Drugs Market: By Region, 2024-2034, USD (Million)
7.3.1.UK and European Union
7.3.1.1. UK
7.3.1.1.1. Genital Herpes Treatment Drugs Market: By Drug Class, 2024-2034, USD (Million)
7.3.1.2. Germany
7.3.1.2.1. Genital Herpes Treatment Drugs Market: By Drug Class, 2024-2034, USD (Million)
7.3.1.3. Spain
7.3.1.3.1. Genital Herpes Treatment Drugs Market: By Drug Class, 2024-2034, USD (Million)
7.3.1.4. Italy
7.3.1.4.1. Genital Herpes Treatment Drugs Market: By Drug Class, 2024-2034, USD (Million)
7.3.1.5. France
7.3.1.5.1. Genital Herpes Treatment Drugs Market: By Drug Class, 2024-2034, USD (Million)
7.3.1.6. Rest of Europe
7.3.1.6.1. Genital Herpes Treatment Drugs Market: By Drug Class, 2024-2034, USD (Million)

8. Asia Pacific Genital Herpes Treatment Drugs Market, 2024-2034, USD (Million)
8.1. Market Overview
8.2. Genital Herpes Treatment Drugs Market: By Drug Class, 2024-2034, USD (Million)
8.3. Genital Herpes Treatment Drugs Market: By Region, 2024-2034, USD (Million)
8.3.1.Asia Pacific
8.3.1.1. China
8.3.1.1.1. Genital Herpes Treatment Drugs Market: By Drug Class, 2024-2034, USD (Million)
8.3.1.2. Japan
8.3.1.2.1. Genital Herpes Treatment Drugs Market: By Drug Class, 2024-2034, USD (Million)
8.3.1.3. India
8.3.1.3.1. Genital Herpes Treatment Drugs Market: By Drug Class, 2024-2034, USD (Million)
8.3.1.4. Australia
8.3.1.4.1. Genital Herpes Treatment Drugs Market: By Drug Class, 2024-2034, USD (Million)
8.3.1.5. South Korea
8.3.1.5.1. Genital Herpes Treatment Drugs Market: By Drug Class, 2024-2034, USD (Million)
8.3.1.6. Rest of Asia Pacific
8.3.1.6.1. Genital Herpes Treatment Drugs Market: By Drug Class, 2024-2034, USD (Million)

9. Latin America Genital Herpes Treatment Drugs Market, 2024-2034, USD (Million)
9.1. Market Overview
9.2. Genital Herpes Treatment Drugs Market: By Drug Class, 2024-2034, USD (Million)
9.3. Genital Herpes Treatment Drugs Market: By Region, 2024-2034, USD (Million)
9.3.1.Latin America
9.3.1.1. Brazil
9.3.1.1.1. Genital Herpes Treatment Drugs Market: By Drug Class, 2024-2034, USD (Million)
9.3.1.2. Mexico
9.3.1.2.1. Genital Herpes Treatment Drugs Market: By Drug Class, 2024-2034, USD (Million)
9.3.1.3. Rest of Latin America
9.3.1.3.1. Genital Herpes Treatment Drugs Market: By Drug Class, 2024-2034, USD (Million)

10. Middle East and Africa Genital Herpes Treatment Drugs Market, 2024-2034, USD (Million)
10.1. Market Overview
10.2. Genital Herpes Treatment Drugs Market: By Drug Class, 2024-2034, USD (Million)
10.3. Genital Herpes Treatment Drugs Market: By Region, 2024-2034, USD (Million)
10.3.1.Middle East and Africa
10.3.1.1. GCC
10.3.1.1.1. Genital Herpes Treatment Drugs Market: By Drug Class, 2024-2034, USD (Million)
10.3.1.2. Africa
10.3.1.2.1. Genital Herpes Treatment Drugs Market: By Drug Class, 2024-2034, USD (Million)
10.3.1.3. Rest of Middle East and Africa
10.3.1.3.1. Genital Herpes Treatment Drugs Market: By Drug Class, 2024-2034, USD (Million)

11. Company Profile
11.1. AstraZeneca, Plc. (Company Overview, Financial Performance, Product Portfolio, Strategic Initiatives)
11.2. Apotheca, Inc.
11.3. Asahi Kasei Pharma Corporation
11.4. Carlsbad Technology, Inc.
11.5. GlaxoSmithKline plc.
11.6. Mylan N.V.
11.7. Novartis AG
11.8. Merck & Co., Inc.
11.9. Teva Pharmaceutical Industries Ltd.
11.10. Zydus Pharmaceuticals, Inc.